Skip to main content
. 2017 Sep 14;6(9):e006695. doi: 10.1161/JAHA.117.006695

Table 1.

Baseline Characteristics

Characteristic Men (n=12 861) Women (n=2967) P Value
Age, y 64.0 (58.0–71.0) 66.0 (61.0–72.0) <0.001
Current smoker 2439 (19.0) 419 (14.1) <0.001
Diabetes mellitus 4836 (37.6) 1300 (43.8) <0.001
Hypertension 9011 (70.1) 2307 (77.8) <0.001
Chronic kidney disease 3637 (28.3) 1152 (38.8) <0.001
Congestive heart failure 2691 (20.9) 691 (23.3) 0.005
Prior MI 7654 (59.5) 1669 (56.3) 0.001
Prior revascularization 9756 (75.9) 2107 (71.0) <0.001
Any history of prior stroke 790 (6.1) 185 (6.2) 0.85
Prior peripheral artery disease 440 (3.4) 111 (3.7) 0.39
Multivessel CHD 1913 (14.9) 477 (16.1) 0.10
Polyvascular disease 1912 (14.9) 460 (15.5) 0.381
Body mass index, kg/m2 28.2 (25.6–31.5) 28.6 (25.3–32.6) <0.001
Region of enrollment <0.001
Asia/Pacific 2526 (19.6) 563 (19.0)
Eastern Europe 2757 (21.4) 774 (26.1)
North America 3330 (25.9) 693 (23.4)
South America 937 (7.3) 262 (8.8)
Western Europe 3311 (25.7) 675 (22.8)
Baseline systolic blood pressure, mm Hg 131 (120–142) 130 (119–143) 0.57
Baseline LpPLA2, μmol/min/L 177.2 (148.8–208.6) 150.4 (125.4–180.7) <0.001
Baseline hs‐CRP, mg/L 1.3 (0.6–2.9) 1.6 (0.8–3.8) 0.002
Baseline HDL cholesterol, mmol/L 1.1 (1.0–1.3) 1.3 (1.1–1.6) <0.001
Baseline LDL cholesterol, mmol/L 2.1 (1.6–2.6) 2.2 (1.7–2.8) <0.001
Baseline HbA1c,* % 7.0 (6.3–8.0) 7.2 (6.5–8.4) <0.001
Baseline eGFR, mL/min/1.73 m2 78.0 (66.0–90.0) 66.0 (60.0–78.0) <0.001

Data provided as median (25th–75th percentiles) or n (%). CHD indicates coronary heart disease; eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; HDL, high‐density lipoprotein; hs‐CRP, high‐sensitivity C‐reactive protein; LDL, low‐density lipoprotein; LpPLA2, lipoprotein‐associated phospholipase A2; MI, myocardial infarction.*Among patients with diabetes mellitus.